Biomod AI

Biomod AI, operating its product under the name Labterna, offers an autonomous "AI in silico designer" for molecular biology teams. The agent takes plain-language task briefs — submitted through a web portal (app.labterna.com) or by email, optionally with attached files, sequences or datasets — and returns completed design work: multiplex qPCR and ddPCR panels, CRISPR guide RNAs and HDR donors, and cloning constructs. Turnaround is stated as hours rather than the weeks a manual workflow would take.

The agent is positioned as computational rather than generative: instead of producing text from a language model's memory, it executes established bioinformatics tools on real data and records each step. A worked example on the company site describes a 12-target EGFR-mutant NSCLC resistance panel with a ddPCR mirror for cfDNA, executed in nine steps across NCBI RefSeq retrieval (GRCh38), Ensembl transcript and exon coordinates, dbSNP variant screening of primer windows, MAFFT alignment, Primer3 candidate generation, BLAST specificity checks against human and mouse genomes, UCSC isPCR pseudogene and paralog screening, thermodynamic QC, and a cross-dimer matrix — reported at 1h 47m run time versus roughly three weeks manually.

Deliverables include publication-ready PDF reports, Excel data files, FASTA sequence files, GenBank construct files and a reproducibility folder containing every script, sequence, method, tool version and literature reference, described as re-runnable and auditable by a reviewer agent. Each customer's agent is configured to the lab's reference genomes, tools, conventions and output formats via a preferences file covering items such as sequencer, oligo supplier, polymerase, cell line, variant allele-frequency filter and report style.

Business model

Service delivered as a dedicated, per-lab AI agent: customers onboard their own genomes, tools and output conventions, then submit design tasks and receive finished reports and data packages. Access is gated behind a work-email sign-up, with a free pilot task and expert review of every output during a pilot month.

Traction

The company publishes case studies from recent research collaborations: a six-target NSCLC hotspot multiplex ddPCR panel for cfDNA with QX200/QX600 channel layouts, 20 genome-verified oligos, 10 synthetic gBlock controls and a CLSI EP17 LoB/LoD plan delivered in about two hours; a 6,871 bp single-vector trastuzumab IgG1 Golden Gate construct for CHO-K1 with zero internal BsaI/BsmBI/SapI sites delivered in about two hours; and a TP53-mCherry endogenous knock-in design in HEK293T with a 2,353 bp HDR donor and zero off-targets at ≤1 mismatch delivered in about one hour.